APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 41 filers reported holding APTINYX INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $9,188 | -78.5% | 73,623 | -50.9% | 0.00% | – |
Q4 2022 | $42,815 | -23.5% | 150,068 | 0.0% | 0.00% | – |
Q3 2022 | $56,000 | -51.7% | 150,068 | -27.9% | 0.00% | – |
Q2 2022 | $116,000 | -76.7% | 208,265 | -5.2% | 0.00% | – |
Q1 2022 | $498,000 | +158.0% | 219,698 | +203.7% | 0.00% | – |
Q4 2021 | $193,000 | +14.2% | 72,341 | 0.0% | 0.00% | – |
Q3 2021 | $169,000 | -68.4% | 72,341 | -61.8% | 0.00% | – |
Q2 2021 | $535,000 | -61.1% | 189,342 | -58.7% | 0.00% | – |
Q1 2021 | $1,377,000 | +9.4% | 458,732 | +26.1% | 0.00% | – |
Q4 2020 | $1,259,000 | +29.7% | 363,917 | +26.6% | 0.00% | – |
Q3 2020 | $971,000 | -21.5% | 287,487 | -3.1% | 0.00% | – |
Q2 2020 | $1,237,000 | +1594.5% | 296,583 | +779.9% | 0.00% | – |
Q1 2020 | $73,000 | -6.4% | 33,708 | +49.0% | 0.00% | – |
Q4 2019 | $78,000 | -1.3% | 22,623 | 0.0% | 0.00% | – |
Q3 2019 | $79,000 | -83.5% | 22,623 | -84.3% | 0.00% | – |
Q2 2019 | $480,000 | -22.0% | 143,850 | -5.2% | 0.00% | – |
Q1 2019 | $615,000 | -75.4% | 151,711 | +0.3% | 0.00% | -100.0% |
Q4 2018 | $2,501,000 | -42.6% | 151,192 | +0.5% | 0.00% | 0.0% |
Q3 2018 | $4,358,000 | +1333.6% | 150,490 | +1098.3% | 0.00% | – |
Q2 2018 | $304,000 | – | 12,559 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
Orbimed Advisors | 538,500 | $300,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |